- Home
- PLMR vs TVTX Comparison
PLMR vs TVTX Comparison
Compare PLMR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLMR | TVTX |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PLMR | TVTX |
|---|---|---|
| Price | $120.96 | $27.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $157.00 | $36.25 |
| AVG Volume (30 Days) | 187.3K | ★ 1.0M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.04 | ★ 92.89 |
| EPS | ★ 7.17 | N/A |
| Revenue | ★ $875,967,000.00 | N/A |
| Revenue This Year | $196.24 | $44.62 |
| Revenue Next Year | $21.31 | $31.76 |
| P/E Ratio | $16.32 | ★ N/A |
| Revenue Growth | ★ 58.16 | N/A |
| 52 Week Low | $107.75 | $12.91 |
| 52 Week High | $175.85 | $42.13 |
Technical Indicators
Market Signals| Indicator | PLMR | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.31 | 46.81 |
| Support Level | $118.35 | $26.72 |
| Resistance Level | $136.40 | $31.47 |
| Average True Range (ATR) | 3.69 | 1.09 |
| MACD | -0.26 | 0.02 |
| Stochastic Oscillator | 56.03 | 57.83 |
Price Performance
Historical ComparisonAbout PLMR Palomar Holdings Inc.
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.